Revance Therapeutics Cash from Investing (TTM) Analysis

Revance Therapeutics Inc (RVNC)

4.10 +0.15 (+3.80%) USD | NASDAQ | May 06, 16:00

3.94 -0.16 (-3.90%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	109.74M
September 30, 2023	148.33M
June 30, 2023	-21.70M
March 31, 2023	-88.05M
December 31, 2022	-138.80M
September 30, 2022	-152.12M
June 30, 2022	-16.86M
March 31, 2022	53.32M
December 31, 2021	-29.66M
September 30, 2021	-66.00M
June 30, 2021	-50.31M
March 31, 2021	79.28M
December 31, 2020	12.13M
September 30, 2020	51.74M
June 30, 2020	20.16M
March 31, 2020	-19.72M
December 31, 2019	-17.59M
September 30, 2019	10.59M
June 30, 2019	40.03M
March 31, 2019	-10.15M
December 31, 2018	-107.03M

Date	Value
September 30, 2018	-69.82M
June 30, 2018	-85.71M
March 31, 2018	-52.95M
December 31, 2017	118.79M
September 30, 2017	-30.35M
June 30, 2017	48.02M
March 31, 2017	40.32M
December 31, 2016	-75.50M
September 30, 2016	-22.21M
June 30, 2016	-116.62M
March 31, 2016	-199.08M
December 31, 2015	-56.42M
September 30, 2015	-58.47M
June 30, 2015	-58.92M
March 31, 2015	-7.791M
December 31, 2014	-6.975M
September 30, 2014	-9.174M
June 30, 2014	-7.502M
March 31, 2014	-7.062M
December 31, 2013	-6.402M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-152.12M

Minimum

Sep 2022

148.33M

Maximum

Sep 2023

-3.973M

Average

-16.86M

Median

Jun 2022

Cash from Investing (TTM) Benchmarks